Ghent University Academic Bibliography

Your filters: cql: author="Demols, A" or (type any "bookEditor issueEditor" and editor="Demols, A")

Add to list
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

R Maréchal, B Vos, M Polus, T Delaunoit, Marc Peeters (UGent) , P Demetter, A Hendlisz, A Demols, D Franchimont, G Verset, et al.

(2012) ANNALS OF ONCOLOGY. 23(6). p.1525-1530
Add to list
- Journal Article
- A1
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study

Stéphanie Laurent (UGent) , Els Monsaert, Tom Boterberg (UGent) , A Demols, I Borbath, M Polus, A Hendlisz, Bernard de Hemptinne (UGent) , C Mahin, P Scalliet, et al.

(2009) ANNALS OF ONCOLOGY. 20(8). p.1369-1374
Add to list
- Conference Paper
- C1
Dose-finding study using oxaliplatin in combination with fixed dose gemcitabin and radiotherapy in patients with locally advanced pancreatic or biliary tract cancer.

E MONSAERT, Tom Boterberg (UGent) , Marc Peeters (UGent) , I BORBATH, A DEMOLS, M POLUS, P SCALLIET, Tine Derre (UGent) and J VAN LAETHEM

(2007) Acta Gastro-Enterologica Belgica. 70.
Add to list
- Journal Article
- A1
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

A DEMOLS, Marc Peeters (UGent) , M POLUS, R MARECHAL, F GAY, ELS MONSAERT, A HENDLISZ and JL VAN LAETHEM

(2006) BRITISH JOURNAL OF CANCER. 94(4). p.481-485
Add to list
- Journal Article
- A1
Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian Phase II study

A DEMOLS, Marc Peeters (UGent) , M POLUS, P HONORE, Tom Boterberg (UGent) , F GAY, MT CLOSON, P VAN HOUTTE, J CLOSSET and JL VAN LAETHEM

(2005) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 62(5). p.1351-1356
Add to list
- Conference Paper
- C1
Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study

J VAN LAETHEM, M POLUS, R MARECHAL, A DEMOLS, F GAY, M MARIJKEN, A HENDLISZ and Marc Peeters (UGent)

(2004) Journal of clinical oncology. 22(14S).
Add to list
- Journal Article
- A1
Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study

JL VAN LAETHEM, P VAN MAELE, C VERSLYPEC, M POLUS, A DEMOLS, G HOUBIERS, P CAENEPEEL, A LELEUX, RR VERMAUT, E VAN CUTSEM, et al.

(2004) ONCOLOGY. 67(5-6). p.338-343
Add to list
- Conference Paper
- C1
Adjuvant gemcitabine (GEM) and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter belgian phase II study

A DEMOLS, Marc Peeters (UGent) , M POLUS, Tom Boterberg (UGent) , Uwe Hesse (UGent) , F GAY and J VAN LAETHEM

(2003) Journal of clinical oncology. 22. p.282-282
Add to list
- Conference Paper
- C1
Raltitrexed/gemcitabine in patients with advanced biliary tract adenocarcinoma: a phase II study

Marc Peeters (UGent) , A DEMOLS, E VAN CUTSEM, P CAENEPEEL, A VERSLYPE, A TAGNON, P VAN MAELE, K DAEMS, R VERMAUT and J VAN LAETHEM

(2003) Journal of clinical oncology. 22. p.357-357

Academic Bibliography

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study

Dose-finding study using oxaliplatin in combination with fixed dose gemcitabin and radiotherapy in patients with locally advanced pancreatic or biliary tract cancer.

Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study

Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: A multicenter Belgian Phase II study

Gemcitabine and oxaliplatine (GEMOX) in gemcitabine-refractory advanced pancreatic cancer: a phase II study

Raltitrexed plus Gemcitabine (TOMGEM) in advanced pancreatic cancer - Results of a Belgian Multicentre Phase II Study

Adjuvant gemcitabine (GEM) and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter belgian phase II study

Raltitrexed/gemcitabine in patients with advanced biliary tract adenocarcinoma: a phase II study

Contents

Support

Contact